Activist Investors Are Back — and This Time They Just Want Companies Sold

Shareholder activism is having a very specific kind of moment. According to Barclays' H1 2026 review, activists launched 136 global campaigns in the first half of the year, up 5% from the same period in 2025. The first quarter was quiet — a hangover from 2025's record 256 campaigns — but Q2 exploded with 74 campaigns, and the demand behind most of them is blunt: sell the company.

As Barclays' Jim Rossman put it, activists are asking why they should waste time fixing companies when the easier argument is a sale. With deal markets rebounding, the classic multi-year operational turnaround pitch is giving way to "run a process, take the premium, move on."

Where the pressure is landing

The US remains the epicenter, with 68 campaigns in H1 — a 13% jump year over year. More than half of all global campaigns targeted technology and industrial companies, sectors activists see as most exposed to AI disruption. That's a notable inversion: for years, tech was where activists went to demand margin discipline. Now they're arguing that AI is rewriting competitive moats fast enough that standalone survival is the riskier bet.

Elliott Management, as usual, is everywhere at once. In July, Elliott built a large stake in CCC Intelligent Solutions, the cloud software firm behind auto-insurance claims workflows, as the company explores a sale. CCC's market value had roughly halved over a year — from about $6.4 billion to $3.3 billion — on slowing growth and weak claims volumes. That's the current activist playbook in miniature: find a fallen software asset, push it into a process while private equity is bidding again. It follows Elliott's earlier moves this year, including a $4 billion PepsiCo position and a near-5% stake in BP.

How this shows up in 13F data

Activist positions are among the most useful signals in institutional filings, because unlike a quant fund's thousand-line portfolio, an activist's book is concentrated and intentional. A few things to keep in mind when tracking them:

The 13F often lags the headline. Activists typically surface via a 13D (crossing 5% with intent to influence) or press reports before the position appears in a quarterly 13F. When the 13F does land, it tells you the full size and whether the stake grew after the public campaign began. You can follow how positions like these build quarter over quarter on our position flow tracker.

Watch for pile-ins. Once an activist goes public, event-driven and merger-arb funds often follow into the same name. If a target shows up as a new buy across multiple unrelated managers in the same quarter, that's the arbitrage community handicapping a deal. Our overlap tool is built for exactly this — spotting when several tracked investors converge on one ticker.

Confidentiality is common. Activists frequently request confidential treatment from the SEC to file positions late, precisely so they can keep accumulating quietly. A position appearing "suddenly" at full size in an amended filing usually means the stake was built over two quarters, not one.

What to watch in the August 14 filings

Q2 2026 13Fs are due by August 14, and this batch should capture the activist surge in progress. Positions initiated during Q2's 74-campaign wave — including stakes built in April through June — will show up at their June 30 size. For campaigns launched in July, like Elliott's CCC stake, you'll only see the beginnings, if anything at all; the full picture waits for the Q3 filings in November.

The more interesting read may be the second-order effects. If activists are right that tech and industrials face AI-driven disruption, watch whether long-only institutional holders are quietly trimming the same names activists are targeting. Divergence between activist accumulation and institutional distribution in the same stock is one of the more reliable tells that a campaign will end in a sale rather than a settlement. You can compare positioning across every manager we track on the investors page, and see how the aggregate stance is shifting on our macro consensus dashboard.

The bigger signal

Activism demanding M&A at this scale is itself a macro data point. It says sophisticated, concentrated capital believes public-market valuations for mid-cap tech and industrials are low enough — and private buyers hungry enough — that the sale premium beats the standalone path. That's a statement about where we are in the deal cycle, and it's one you can verify, position by position, as the filings roll in this month.

---

Data sourced from public SEC 13F filings. Educational research only — not investment advice.